Table 2.
Peripheral measures in vehicle- and AAS-treated adolescent and adult males
Experiment | Adolescent males |
Adult males |
||
---|---|---|---|---|
Vehicle treated (mean ± SEM) | AAS treated (mean ± SEM) | Vehicle treated (mean ± SEM) | AAS treated (mean ± SEM) | |
Testes weight (g) | ||||
1 | 2.31 ± 0.04 | 2.0 ± 0.04 * | 3.85 ± 0.13 | 3.29 ± 0.10 * |
2 | 2.06 ± 0.07 | 1.70 ± 0.07 * | 3.86 ± 0.09 | 3.67 ± 0.07 * |
Seminal vesicle weight (g) | ||||
1 | 0.167 ± 0.01 | 0.114 ± 0.02 * | 0.344 ± 0.02 | 0.273 ± 0.02 * |
2 | 0.21 ± 0.01 | 0.16 ± 0.01 * | 0.36 ± 0.03 | 0.32 ± 0.03 * |
Flank gland diameter (mm) | ||||
1 | 6.77 ± 0.33 | 8.24 ± 0.34 * | 7.6 ± 0.40 | 7.75 ± 0.19 * |
2 | 7 ± 0.3 | 7.9 ± 0.3 | 8.5 ± 0.26 | 8.5 ± 0.25 |
Body weight—beginning of treatment period (g) | ||||
1 | 56.41 ± 1.12 | 59.49 ± 2.0 | 106.14 ± 4.17 | 107 ± 2.03 |
2 | 49.67 ± 1.0 | 47.23 ± 1.6 | 107.78 ± 2.6 | 108.61 ± 1.9 |
Body weight—end of treatment period (g) | ||||
1 | 93.36 ± 2.33 | 90.10 ± 1.81 | 113.32 ± 4.83 | 111.39 ± 2.36 |
2 | 86.9 ± 1.8 | 81.8 ± 2.1 * | 120.53 ± 2.9 | 116.0 ± 2.1 * |
Main effect of treatment in two-way ANOVA, p<0.05.